CRI’s Andrew Pleasant Participates in FDA Advisory Committee Meeting

CRI Senior Director for Health Literacy and Research Andrew Pleasant, Ph.D., joined with fellow members of the Food & Drug Administration’s Risk Communication Advisory Committee in meeting with FDA leaders. They discussed best practices in risk communication, health literacy, communication about public health issues, and how those best practices should be put to use by the FDA.